US 10005740
Neprilysin inhibitors
granted A61KA61K31/415A61K31/4192
Quick answer
US patent 10005740 (Neprilysin inhibitors) held by Theravance Biopharma R&D IP, LLC expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/415, A61K31/4192, A61K31/4196, A61K31/42